Paid Clinical Trials in Fullerton, CA
As of August 2026, 96 paid clinical trials are recruiting in Fullerton, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Fullerton offers studies at sites including Providence Medical Foundation for conditions such as Advanced Solid Tumor, Carcinoma, Non-Small-Cell Lung, Breast Neoplasms, Esophageal Squamous Cell Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Fullerton
Trials by drug in Fullerton
Filter results
Newly added in Fullerton
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
93 clinical trials
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Top Research Study Locations in Fullerton
Researchers run research studies in Fullerton, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Medical Foundation | Advanced Solid Tumor, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small Cell Lung | 28 |
| Providence St. Jude Medical Center | Advanced Breast Cancer, Advanced Ovarian Cancer, Advanced Solid Tumor | 7 |
| Retina Consultants of Orange County | Diabetic Macular Edema (DME), AMD, DME | 6 |
| Neurology Center of North Orange County | AD, Agitation, Alzheimer Disease | 5 |
| Fullerton Neuro and Headache Ctr | Generalized Myasthenia Gravis, Secondary Progressive Multiple Sclerosis (SPMS) | 3 |
| Marshall B. Ketchum University | Amblyopia, Dry Eye Disease (DED), Myopia | 3 |
| Providence Saint Jude Medical Center | Extensive Stage Small-cell Lung Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer | 3 |
| St. Jude Medical Center | Advanced Non-Small-Cell Lung Cancer, Atrial Fibrillation, Central Line Associated Blood Stream Infections (CLABSI) | 3 |
| Providence - St. Jude Medical Center | Hypothyroidism, Multiple Myeloma, Non Small Cell Lung Carcinoma | 3 |
| Fullerton Neurology and Headache Center | Alzheimer's Disease, Secondary Progressive Multiple Sclerosis | 2 |
| Southern California College of Optometry at Marshall B. Ketchum University | Intermittent Exotropia, Myopia | 2 |
| Providence Medical Foundation-Oncology | Breast Neoplasms, Diffuse Large B-Cell Lymphoma | 2 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Adverum | Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD | 1 |
| Alliance Surgery Center, Inc | Lumbar Spinal Stenosis | 1 |
| Clinical Research Providence Medical Foundation | Small Cell Lung Cancer | 1 |
| Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton | Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreatic Cancer | 1 |
| Davita Fullerton Dialysis Center | End Stage Kidney Disease | 1 |
| Fullerton Neurological Center - Neurology | Chronic Migraine, Episodic Migraine | 1 |
| GSK Investigational Site | Systemic Lupus Erythematosus | 1 |
| Investigative | Solid Tumors | 1 |
| Laguna Surgery Center | Lumbar Spinal Stenosis | 1 |
| Local Institution - 0162 | Urothelial Cancer | 1 |
| Local Institution - 0504 | Non-Small Cell Lung Cancer | 1 |
| Local Institution - 0581 | Carcinoma, Non-Small-Cell Lung | 1 |
Active & Upcoming Studies in Fullerton (2026)
Recruiting trials in Fullerton grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (49 active studies)
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
- IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) · Phase 3 · Ono Pharmaceutical Co., Ltd.
Eye & vision (9 active studies)
- Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration · Phase 2 · Adverum Biotechnologies, Inc.
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
Neurology & pain (5 active studies)
- A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis · Phase 3 · Zenas BioPharma (USA), LLC
- A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis · Phase 3 · Novartis Pharmaceuticals
Cardiovascular (2 active studies)
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure · Phase 3 · AstraZeneca
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery · Phase 3 · Yale University
Diabetes & metabolic (1 active study)
- AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight · Phase 3 · Novo Nordisk A/S
Common conditions studied in Fullerton
- Advanced Solid Tumor (4 active studies)
- Carcinoma, Non-Small-Cell Lung (4 active studies)
- Breast Neoplasms (3 active studies)
- Esophageal Squamous Cell Carcinoma (3 active studies)
- Non-Small Cell Lung Cancer (3 active studies)
- Amblyopia (2 active studies)
Leading research sponsors in Fullerton
- Merck Sharp & Dohme LLC
- Amgen
- Janssen Research & Development, LLC
- AbbVie
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Fullerton?
There are approximately 96 recruiting clinical trials in Fullerton, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fullerton pay participants?
Most recruiting trials in Fullerton compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fullerton?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fullerton?
The most common conditions under active study in Fullerton include Advanced Solid Tumor (4), Carcinoma, Non-Small-Cell Lung (4), Breast Neoplasms (3), Esophageal Squamous Cell Carcinoma (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fullerton?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fullerton on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fullerton?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fullerton?
Recruiting research sites in Fullerton include Providence Medical Foundation, Providence St. Jude Medical Center, Retina Consultants of Orange County, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fullerton right now?
The largest active categories in Fullerton are Cancer & tumors (49), Eye & vision (9), Neurology & pain (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.